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Abstract
Background: Heat shock proteins (HSPs) are found in all prokaryotes and most compartments of eukaryotic cells.
Members of the HSP family mediate immune responses to tissue damage or cellular stress. However, little is known
about the immune response induced by the oriental liver fluke, Clonorchis sinensis, even though this organism is
carcinogenic to humans. We address this issue in the present study in mouse bone marrow dendritic cells
(mBMDCs), using recombinant HSP70 and 90 from C. sinensis (rCsHSP70 and rCsHSP90).
Methods: rCsHSP70 and rCsHSP90 were produced in an E. coli system. Purified recombinant proteins were treated
in BMDCs isolated from C57BL/6 mice. T cells were isolated from Balb/c mice and co-cultured with activated
mBMDCs. Expression of surface molecules was measured by flow cytometry and cytokine secretion was quantified
using ELISA. C57BL/6 mice were divided into four groups, including peptide alone, peptide/Freund’s adjuvant,
peptide/CsHSP70, peptide/CsHSP90, and were immunized intraperitoneally three times. Two weeks after final
immunization, antibodies against peptide were measured using ELISA.
Results: Both proteins induced a dose-dependent upregulation in major histocompatibility complex and co-stimulatory
molecule expression and increased secretion of pro-inflammatory cytokines including interleukin (IL)-1β, -6, and -12p70
and tumor necrosis factor-α in mBMDCs. Furthermore, when allogenic T cells were incubated with mBMDCs activated
by rCsHSP70 and rCsHSP90, the helper T cell (Th)1 cytokine interferon-γ was up-regulated whereas the level of the Th2
cytokine IL-4 was unchanged. These results indicate that rCsHSPs predominantly induce a Th1 response. Over and above
these results, we also demonstrated that the production of peptide-specific antibodies can be activated after
immunization via in vitro peptide binding with rCsHSP70 or rCsHSP90.
Conclusion: This study showed for the first time that the HSP or HSP/peptide complexes of C. sinensis could be
considered as a more effective vaccine against C. sinensis infection as results of the activator of host immune response
as well as the adjuvant for antigenic peptide conjugate to induce peptide-specific antibody response in mice.
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Background
Clonorchis sinensis is a fish-borne parasitic trematode
widely distributed in Korea, China, Taiwan, Vietnam, and
Russia that is the causative agent of human clonorchiasis [1],
which mainly occurs as a result of eating raw or under-
cooked freshwater fish infested with the metacercariae of C.
sinensis [2–4]. Eating uncooked fish is also an important risk
factor for intrahepatic CCA caused by clonorchiasis [5]. In
2009, C. sinensis was classified as a Group 1 carcinogen in
humans by the International Agency for Research on Cancer
[6]. The most common cause of death by clonorchiasis is
cholangiocarcinoma (CCA) [7], a cancer of the bile ducts
that is associated with chronic and severe liver fluke infection
[1]; continuous stimulation of the bile duct by this organism
induces pathological changes such as biliary mucosal hyper-
plasia, bile duct enlargement, periductal fibrosis, mechanical
obstruction, inflammation, epithelial adenomatous hyperpla-
sia, and biliary cirrhosis [1, 2, 8]. The association between
liver flukes and CCA has also been demonstrated animal
models [9]. Advanced CCA typically has poor prognosis,
with a median survival time of < 24 months [5, 10]; around
5,000 cases of CCA attributed to C. sinensis infection are re-
ported worldwide each year [11]. A survey in Korea showed
that the ratio of patients with CCA differed significantly be-
tween those with and without clonorchiasis [12]. As such,
considerable effort has been focused on the development of
a vaccine against C. sinensis. One study reported the protect-
ive effect of Cs14-3-3 epsilon protein [13] while another
showed that CsTP22.3 expressed by Bacillus subtilis spores
was immunogenic and could be orally administered to pro-
vide protection against C. sinensis infection [14].
Heat shock proteins (HSPs) constitute a highly con-
served family in most organisms that provide cellular
protection under stressful conditions including heat, oxi-
dative stress, glucose starvation, irradiation and viral in-
fection [15]. HSP70 and HSP90 provide a link between
innate and adaptive immune responses via activation of
lymphocytes and antigen-presenting cells (APCs) such
as dendritic cells (DCs) [15, 16]. HSPs purified from bac-
terial and mammalian sources are potent stimulators of
the innate immune response [16], which includes pro-
duction of pro-inflammatory cytokines such as tumor
necrosis factor (TNF)-α and interleukin (IL)-1β, -6, and
-12 by macrophages [17] and DCs [18, 19] and the up-
regulation of surface markers such as cluster of differen-
tiation (CD)40, CD80, and CD86 in DCs [20]. HSPs also
induce antigen-dependent T cell activation as well as
interferon (IFN)-γ secretion [21, 22], and are associated
with peptides that are presented by major histocompati-
bility complex (MHC), MHC II and MHC I on APCs
[23–25]. Antigenic peptide/HSP70 complexes activate
DCs for cytokine release and prime cytotoxic T lympho-
cyte (CTL) responses [18, 26]. Mice immunized with
HSP/CTL epitope peptide complexes produced CTLs and
showed a peptide-specific antibody response [27]. Various
studies have shown that immunization with parasite HSPs
induce cellular and humoral immune responses and pro-
tect against infection by the parasite [20, 28–31]. These
findings suggest that pathogen HSPs are a candidate vac-
cine against infectious diseases. However, no studies have
been done on host immune responses to HSPs in trema-
todes, including C. sinensis despite its risk to humans.
We addressed this in the present study by investigating in
vitro immune responses to C. sinensis HSP70 and HSP90.
Their adjuvant effect was confirmed by analyzing anti-
peptide antibody production after immunization of peptide
bound to CsHSP70 and CsHSP90 in a murine model.
Methods
Recombinant C. sinensis (rCsHSP) expression and purification
cDNA clones encoding CsHSP70 and CsHSP90 were ob-
tained from the adult C. sinensis cDNA library. The
open reading frames of the two proteins were PCR-
amplified using the following forward and reverse primer
sets: CsHSP70, 5'-GAG CGA TCT CAT GTC GAA
GGT CAT GCT-3' and 5'-CGC GTC GAC CTA TTG
TTT CTG CTG AG-3'; and CsHSP90, 5'-GCA ATT
CCA TAT GTC TTG CGA ACC GAT GGC-3' and 5'-C
CC AAG CTT ATC GAC TTC TTC CAT TCC AGC-3'.
The PCR products were cloned into the pET28a and
pET21a vectors (Novagen, Madison, WI, USA), respect-
ively. Recombinant plasmids were transformed into Escher-
ichia coli BL21 (DE3)-RIPL cells, which were grown in
Luria-Bertani medium containing ampicillin or kanamycin.
Isopropyl-B-D-thiogalactopyranoside was added to the cul-
ture to a final concentration of 0.5 mM and cells were incu-
bated for 20 h at 16 °C, then harvested by centrifugation
and resuspended in lysis buffer [50 mM NaH2PO4,
300 mM NaCl, and 5 mM imidazole (pH 8.0)]. The cell
suspension was sonicated on ice, and supernatants were
collected after centrifugation. Recombinant proteins were
purified using Ni-nitrilotriacetic acid agarose (Qiagen, Val-
encia, CA, USA) under native conditions. Briefly, superna-
tants were loaded in a column pre-equilibrated with lysis
buffer. The column was washed with five bed volumes of
wash buffer [50 mM NaH2PO4, 300 mM NaCl, and 20 mM
imidazole (pH 8.0)] and then eluted with elution buffer
[50 mM NaH2PO4, 300 mM NaCl, 250 mM imidazole
(pH 8.0)]. The eluted protein fraction was concentrated
using Amicon Ultra-4 centrifugal filter devices (Millipore,
Billerica, MA, USA) and protein concentration was esti-
mated by the Bradford method using bovine serum albu-
min as a standard. The purity of eluted proteins was
evaluated by sodium dodecyl sulfate polyacrylamide gel
electrophoresis (SDS-PAGE) and sequences were con-
firmed by liquid chromatography–tandem mass spectrom-
etry (LC-MS/MS). Recombinant proteins were dialyzed
against Dulbecco’s phosphate buffered saline (DPBS;
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pH 7.4) for mouse immunization or treatment of mouse
bone marrow dendritic cells (mBMDCs).
Before experiments, endotoxin contaminants of rCsHSP70
and rCsHSP90 were removed using Detoxi-Gel endotoxin
removal columns (Pierce, Rockford, IL, USA). The endotoxin
level in recombinant proteins was determined with the
Limulus amoebocyte lysate (LAL) Chromogenic Endotoxin
Quantitation kit (Pierce) and was found to be negli-
gible (<1 EU/ml). Additionally, rCsHSPs were pre-incubated
with polymyxin B (Sigma-Aldrich, St. Louis, MO, USA)
before being used for mBMDC treatment.
mBMDC preparation
Femurs and tibiae were removed from C57BL/6 mice and
washed with DPBS. Both ends of isolated bones were cut
with scissors and the bone marrow was flushed out with
ice-cold DPBS using a syringe. After one wash with DPBS,
erythrocytes were lysed by treatment with red blood cell
lysis buffer (Sigma-Aldrich). mBMDCs were obtained by
culturing the cells (2 × 106 cells/ml) in the presence of
20 ng/ml recombinant granulocyte–macrophage colony-
stimulating factor (GM-CSF; Peprotech, Rocky Hill, NJ,
USA) for 8 days in RF10 medium (Roswell Park Memorial
Institute (RPMI)-1640 medium (Gibco, Carlsbad, CA,
USA) supplemented with 10% fetal bovine serum (FBS;
Gibco), 1% penicillin-streptomycin, and L-glutamine). The
medium was replaced every 3 days.
Analysis of DC-secreted cytokines and DC surface markers
After 8 days, cells were harvested and resuspended in RF10
medium containing GM-CSF. Cells were then seeded in a
6-well plate at a density of 2 × 106 cells/well. rCsHSPs or
proline-rich (ProR) peptide were mixed with 50 μg/ml poly-
myxin B and incubated at 4 °C. After 1 h, immature DCs
were stimulated with rCsHSP70, rCsHSP90, ProR peptide,
or 0.1 μg/ml lipopolysaccharide (LPS; Sigma-Aldrich) as a
positive control for 18 h in humidified 5% CO2 incubator at
37 °C. After treatment, cells were harvested and centrifuged
at 2000× g for 5 min. The supernatant was collected and
stored at −20 °C until use. Cells were then labeled with
fluorescein isothiocyanate (FITC)-conjugated anti-mouse
CD11c antibody; phycoerythrin (PE)-conjugated anti-
mouse CD40, CD80, or CD86 antibody; or allophycocyanin
(APC)-conjugated MHC Class II (I-A/I-E) or MHC Class I
(H-2 kb) antibody (all from eBioscience, San Diego, CA,
USA) for 30 min at 4 °C. After 30 min of labeling, cells
were washed with DPBS and resuspended in 4% parafor-
maldehyde for analysis with a FACSVerse flow cytometer
(BD Biosciences, Franklin Lakes, NJ, USA); data were ana-
lyzed using FlowJo software (Ashland, OR, USA). Levels of
interleukin (IL)-6, -1β, -12p70, and -10 and TNF-α in cul-
ture supernatants were quantified with an enzyme-linked
immunosorbent assay (ELISA) kit (R&D Systems,
Minneapolis, MN, USA), according to the manufacturer’s
instructions.
Measurement of intracellular cytokine levels in DCs
Intracellular cytokines were detected using the Cytofix/
Cytoperm kit (BD Biosciences), according to the manu-
facturer’s instructions. Briefly, DCs (1 × 106 cells/ml)
treated with rCsHSPs were harvested and centrifuged at
1500× rpm for 5 min. The supernatant was removed and
the pellet was washed with staining buffer (2.5% FBS in
DPBS), and 1 μg/ml of FITC-conjugated anti-mouse
CD11c IgG (eBioscience) was added followed by incuba-
tion at 4 °C for 30 min. The pellets were washed twice
with staining buffer and cells were collected by centrifu-
gation. The pellets were resuspended and incubated in
250 μl of Cytofix/Cytoperm solution (BD Biosciences)
for 20 min at 4 °C, then washed twice in 1× Perm/Wash
solution (BD Biosciences). To label intracellular cyto-
kines, cells were incubated in 1 μg/ml PE-conjugated
anti-mouse IL-10 or-12 or IFN-γ IgG solution (eBios-
ciences) at 4 °C for 30 min in the dark, then washed
twice in 1× Perm/Wash solution and fixed with 4%
paraformaldehyde at 4 °C. The fluorescence intensity of
intracellular cytokines was measured by flow cytometry.
Endocytosis test
To analyze the endocytic capacity of DCs, 1 × 106 cells were
incubated in the presence or absence of rCsHSPs for 20 h.
The cells were harvested and washed twice with DPBS, and
1 × 106 cells were incubated at 37 °C or 4 °C for an additional
30 min with 1 mg/ml FITC-dextran (40,000 MW anionic,
lysine-fixable; Molecular Probes, Eugene, OR, USA). After
incubation, cells were washed twice with ice-cold staining
buffer (0.1% FBS and 0.01% NaN3 in PBS), and 1 μg/ml
PE-conjugated anti-mouse CD11c IgG (eBioscience) was
added followed by incubation at 4 °C for 30 min. After
two washes, labeled DCs were analyzed by flow cytometry.
Allogenic mixed lymphocyte reaction (MLR)
T cells were prepared from splenocytes obtained by
grinding spleens of 8-week-old BALB/c mice. CD3+ T
cells were purified via negative selection using magnetic-
activated cell sorting (MACS) columns (Pan T Cell
Isolation Kit II; Miltenyi Biotec, San Diego, CA, USA).
Isolated T cells were stained with carboxyfluorescein
succinimidyl ester (CFSE) using the Cell Trace CFSE
Cell Proliferation kit (Molecular Probes). BMDCs (5 ×
104 cells/well) were stimulated with 10 μg/ml rCsHSPs for
24 h, washed twice, and then co-cultured with CFSE-
labeled T cells (5 × 105 cells/well). Mixed cells were added
to a 96-well round-bottom plate and cultured in humidified
5% CO2 incubator at 37 °C. Cells were harvested after 4, 5,
and 6 days and supernatants were collected and stored at
−20 °C until analysis. Harvested cells were washed twice
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and then stained with 1 μg/ml PE-conjugated anti-mouse
CD3e antibody (eBioscience) at 4 °C for 30 min. After
two washes with DPBS, the cells were resuspended
in 4% paraformaldehyde and fluorescence intensity
was measured by flow cytometry. IL-2 and -4 and
IFN-γ concentrations in the cell culture supernatant
were measured with ELISA kits (R&D Systems), ac-
cording to the manufacturer’s instructions.
rCsHSPs immunization and measurement of cytokines
secreted from splenocytes
Groups of 5 C57BL/6 mice were immunized intraperitone-
ally with 50 μg of rCsHSP70 or rCsHSP90 emulsified in
complete Freund’s adjuvant (CFA). Subsequent booster doses
were given on 14th and 28th day with 50 μg of rCsHSP70 or
rCsHSP90 emulsified in incomplete Freund’s adjuvant (IFA).
The control mice received an equal volume of PBS mixed
with adjuvant. After the 7th day of the last immunization,
the splenocytes were isolated from mice and cultured (1 ×
105 cells/well) either in the absence or presence of 5 μg/ml
of rCsHSPs for 72 h. The levels of IL-2, -4 and IFN-γ in cul-
ture supernatants were determined using ELISA kits (R&D
system), according to the manufacturer’s instructions.
rCsHSPs/CsProR peptide complex formation
CsProR peptide (> 95% purity; DAPVPKSGGPDAPVP
KSGGPDAPVPKSGG) was synthesized by Peptron (Daejeon,
Korea). The ProR sequence was derived from the proline-rich
antigen of C. sinensis (GenBank accession no. AAK35165).
To prepare rCsHSPs/CsProR peptide complexes, CsHSP70
or CsHSP90 was mixed with CsProR peptide for 1 h in bind-
ing buffer [1 mM ADP and 1 mM MgCl2 in DPBS (pH 7.4)]
at 37 °C with shaking. After 1 h of incubation, 50 μg/ml
polymyxin B was added, and complexes were incubated at
4 °C for 1 h, then immediately transferred to ice until use.
Immunization with CsHSPs/ProR peptide complexes
C57BL/6 mice were divided into four groups of five ani-
mals each as follows: group 1 was immunized with ProR
peptide alone; group 2 was immunized with ProR pep-
tide combined with Freund’s adjuvant (FA); group three
was immunized with CsHSP70/ProR peptide complexes;
and group four was immunized with CsHSP90/ProR
peptide complexes. Mice were intraperitoneally injected
three times at 2-week intervals with complete FA for the
first injection and incomplete FA for the first and second
boosts. After final immunization, whole blood was
collected from each mouse by cardiac puncture and
centrifuged at 2000× rpm and 4 °C for 10 min. Obtained
serum samples were stored at -20 °C until analysis.
Analysis of T cell proliferation
Splenocytes were prepared by grinding the spleens of five
immunized mice from each group. T cells were purified
from splenocytes via negative selection using MACS col-
umns. Prepared T cells were cultured in a 96-well plate at
a density of 1 × 105 cells/well in a final volume of 100 μl/
well after resuspension in cell culture medium (RPMI
1640 with 10% FBS and 1% antibiotics). The plate was
incubated in the absence or presence of ProR peptide
(10 μg/ml) at 37 °C in a 5% CO2 incubator for 72 h before
10 μl/well WST-1/electro coupling solution (BioVision,
Milpitas, CA, USA) was added to each well. The cells were
incubated under standard culture conditions for 4 h, and
sample absorbance was measured using a microplate
reader at 450 nm (reference wavelength: 620 nm).
Determination of antibody titer
Humoral immune responses elicited by ProR peptide/
rCsHSPs complexes were analyzed by detecting the
production of specific antibodies against the peptide in
CsProR peptide-coated ELISA plates. Briefly, streptavidin-
coated 96-well plates (Thermo Fisher Scientific, Waltham,
MA, USA) were incubated with 5 μg/ml biotin-conjugated
CsProR peptide for 18 h at 4 °C. All subsequent steps were
carried out at room temperature. After three washes with
PBS containing 0.1% Triton X-100 (PBST), plates were
blocked with blocking buffer (5% skim milk in PBST) for
2 h, washed, and incubated in immunized mouse serum di-
luted in blocking buffer for 2 h. After washing, 100 μl/well
horseradish peroxidase-conjugated rabbit anti-mouse IgG
(Sigma-Aldrich) diluted 1:10,000 in blocking buffer were
added, followed by incubation for 2 h; 50 μl/well 3,3′,5,5′-
tetramethylbenzidine/H2O2 substrate were added, followed
by incubation for 30 min. The enzymatic reaction was
terminated by adding 50 μl/well of 2 N H2SO4 to the wells
and optical density was measured with a spectrophotometer
at 450 nm (reference wavelength: 620 nm). For measuring
IgG isotypes, detection of antibodies was determined using
either horseradish peroxidase-conjugated goat anti-mouse
IgG1 or IgG2a (BioRad, Hercules, CA, USA).
Statistics analysis
Statistical analyses were performed using two-tailed
t-tests or 2 way ANOVA run on GraphPad Prism ver-
sion 5.01 software (GraphPad Software, San Diego, CA).
Experimental data were presented as the standard error
of the mean (SEM). Differences between groups were
considered significant if P-value was less than 0.05.
Results
Purification of rCsHSP70 and rCsHSP90
CsHSP70 and CsHSP90 are 656 and 714 amino acids,
respectively, with predicted molecular weights of 75 and
83.3 kDa, respectively. The expression of these proteins
was confirmed by the band size in the SDS-PAGE
analysis (Fig. 1); the purified proteins had significant
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homology (P < 0.05) to the known sequences of CsHSP70
and CsHSP90, as determined by LC-MS/MS.
rCsHSPs increase surface marker expression and cytokine
production in mBMDCs
rCsHSP70 and rCsHSP90 with endotoxins removed in-
duced the expression of co-stimulatory molecules by
mBMDCs in a dose-dependent manner (Fig. 2). rCsHSP
induced mBMDC maturation, as demonstrated by the
upregulation of the co-stimulatory molecules CD40,
CD80, and CD86, whereas treatment with either protein
dose-dependently increased MHC I and MHC II expres-
sion. Moreover, MHC I expression was higher than in
the LPS-treated positive control group.
Cytokines secreted from activated DCs are classified as
Th2-type cytokines (e.g., IL-10) or pro-inflammatory cy-
tokines (e.g., IL-12p70, -6, and -1β and TNF-α) [18, 32].
We measured the concentration of these cytokines
secreted from mBMDCs by ELISA in cell culture super-
natants. There was a dose-dependent increase in the
Fig. 1 SDS-PAGE images of rCsHSPs expression. a rCsHSP70 and b rCsHSP90 were purified under native conditions and resolved by 10%
SDS-PAGE. Molecular weight markers are indicated in left. Lane 1: total induced cell lysate; Lane 2: supernatant (sup); Lane 3: flow through; Lanes
4–5: wash; Lanes 6–10: eluted fraction. rCsHSPs are indicated by arrows
Fig. 2 Increase in expression of BMDC surface markers by rCsHSPs. BMDCs from C57BL/6 mice were cultured for 7 days and then incubated for
22 h with rCsHSP70 or rCsHSP90. Cells were harvested and labeled with FITC-conjugated anti-mouse CD11c or PE-conjugated anti-mouse CD40,
CD80, CD86, MHCI, or MHCII antibodies on ice for 30 min. Fluorescence intensity was measured by flow cytometry
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secreted levels of pro-inflammatory cytokines (IL-12p70,
-6, and -1β and TNF-α) following treatment with
rCsHSP70 (t(2) = 12.25, P = 0.0066) or rCsHSP90 (t(2) =
16.22, P = 0.0038). IL-10 level was also slightly in-
creased by high concentrations of rCsHSP70 (t(2) =
9.065, P = 0.012) or rCsHSP90 (t(2) = 27.01, P = 0.0014)
(Fig. 3). In addition, measurement of intracellular IL-10
and -12 production by flow cytometry revealed an
increase in IL-12 level according to rCsHSP concentra-
tion, whereas IL-10 was not detected (Fig. 4).
rCsHSP70 and rCsHSP90 are taken up as antigens by
mBMDCs
DCs mature following antigen uptake and subsequently
decrease their endocytic activity [33, 34]. We investi-
gated whether rCsHSPs affect the endocytic capacity of
Fig. 3 rCsHSPs dose-dependently induce cytokine secretion by BMDCs. BMDCs from C57BL/6 mice were cultured for 7 days and then incubated
for 22 h with rCsHSP70 or rCsHSP90. Secreted cytokine levels in culture supernatants were measured by ELISA. The results are shown as the mean
± standard error (SEM). *P < 0.05, **P < 0.01, ***P < 0.001 compared to PBS-treated group
Fig. 4 rCsHSPs increase production of intracellular IL-12 in CD11c+ mBMDCs. mBMDCs were stimulated with rCsHSP70 and rCsHSP90 for 18 h,
then labeled with FITC-conjugated CD11c antibody before permeabilization. Intracellular cytokines were labeled with PE-conjugated antibodies
against mouse IL-12, IL-10, and IFN-γ. The number of cytokine-producing cells was determined by flow cytometry
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mBMDCs treated with FITC-conjugated dextran and
activated with rCsHSPs (Fig. 5). Immature mBMDCs
captured a large amount of dextran-FITC at 37 °C rela-
tive to the non-specific control at 4 °C. This uptake was
abrogated upon treatment with 5 μg/ml rCsHSPs to a
level similar to that induced by the positive control LPS
(0.1 μg/ml).
mBMDCs activated by CsHSP70 and CsHSP90 induce T
cell proliferation and differentiation
To further investigate the cellular response elicited by
rCsHSPs, we evaluated T lymphocyte proliferation and
cytokine secretion in response to stimulation with 5 μg/
ml rCsHSPs. mBMDCs activated with rCsHSPs were co-
cultured with T cells isolated from splenocytes of allo-
genic mice; T cell activation was confirmed by MLR.
The number of T cells stimulated with mature BMDCs
increased in a time-dependent manner (Fig. 6a). In
addition, IL-2 (CsHSP70; t(2) = 5.322, P = 0.0335, CsHSP90;
t(2) = 5.257, P = 0.0343) and IFN-γ levels (CsHSP70: t(2) =
4.85, P = 0.04; CsHSP90: t(2) = 23.83, P = 0.0018) in T cells
were increased relative to the PBS-treated group in re-
sponse to rCsHSPs stimulation, although IL-4 level was
slightly increased in case of rCsHSP90-treatment (t(2) =
10.15, P = 0.0096) (Fig. 6b).
rCsHSP70 and rCsHSP90 stimulate IFN-γ secretion from
splenocytes of immunized mice
We also measured cytokines secreted from splenocytes
after re-stimulation in rCsHSPs-immunized mice (Fig. 7).
The levels of IFN-γ produced in the splenocytes in re-
sponse to rCsHSP70 (t(8) = 7.757, P < 0.0001) and
rCsHSP90 (t(8) = 3.398, P = 0.0094) stimulation were sig-
nificantly higher in cells isolated from immunized mice
Fig. 5 Reduced endocytic capacity of BMDCs by rCsHSP70 and rCsHSP90 treatment. mBMDCs treated with rCsHSPs or LPS were incubated with
FITC-labeled dextran for 30 min at 4 °C or 37 °C. Endocytic capacity was analyzed by flow cytometry
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as compared to PBS-immunized control mice. But IL-2
and IL-4 were not changed. This result was consistent
with the results of in vitro experiments.
rCsHSPs/ProR peptide complexes increase cytokine
secretion from mBMDCs
HSPs act as adjuvants in antigen presentation. To verify
whether CsHSPs serve this function, we examined
mBMDC activation by CsHSP70 or CsHSP90 bound to an
antigenic peptide that cannot be presented as an antigen,
by itself. ProR peptide of C. sinensis is a strong antigenic
peptide that we previously detected in the sera of
clonorchiasis patients (data not shown); we therefore
tested whether the ProR peptide alone or in a complex
with rCsHSP70 or rCsHSP90 could induce cellular im-
munity. When mBMDCs were stimulated with ProR pep-
tide alone, surface molecule expression increased only at
high concentration (Fig. 8) and cytokine secretion were
unaltered (Fig. 9). However, CsHSP70/ProR peptide com-
plexes increased TNF-α (t(2) = 4.501, P = 0.046) and IL-6
(t(2) = 9.817, P = 0.0102) and -1β (t(2) = 40.91, P = 0.0006)
secretion from mBMDCs, and CsHSP90/ProR peptide
complexes also stimulate IL-6 (t(2) = 12.66, P = 0.0062) and
-1β (t(2) = 4.821, P = 0.0404) secretion by mBMDCs (Fig. 9),
Fig. 6 mBMDCs matured by stimulation with rCsHSPs show increased T cell proliferation and T cell secretion of IL-2 and IFN-γ. mBMDCs were
incubated overnight with rCsHSP70, rCsHSP90, or LPS as indicated. mBMDCs were then washed and co-cultured with CFSE-labeled T cells. a T cell
proliferation was evaluated after 4, 5 and 6 days by flow cytometry. X- and y-axes indicates fluorescence intensity for CFSE and number of cells,
respectively. b IL-2 secretion was quantified after 16 h; IL-4 and IFN-γ levels were measured after 5 days by ELISA. The results are shown as the
mean ± standard error (SEM) and are representative of three independent experiments. *P < 0.05, **P < 0.01 compared to PBS-treated group
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although surface marker expression was unaffected (data
not shown).
rCsHSPs stimulate CsProR peptide-specific antibody
production
We next examined whether CsHSP70 and CsHSP90
induce production of peptide-specific antibodies. To
assess in vivo immune responses, ProR peptide was
mixed with rCsHSPs or FA and used to immunize
mice. T cells isolated from the splenocytes of immu-
nized mice were re-stimulated with 10 μg/ml ProR
peptide, and anti-ProR antibody levels were measured
in mouse serum. The T cell proliferation test revealed
that the number of T cells did not increase in mice
immunized with the peptide mixed with rCsHSPs or
FA (Fig. 10a). However, the production of antibodies
against ProR peptide was enhanced in mice immu-
nized with CsHSP70/ProR peptide (F(7,7) = 86.69, P <
0.0001) or CsHSP90/ProR peptide (F(7,7) = 18.51, P =
0.001) complexes (Fig. 10b), with a stronger effect ob-
served for rCsHSP70 than for rCsHSP90. Moreover,
to determine the type of immune response, the iso-
type IgG1 and IgG2a was determined using ELISA.
The results revealed that IgG1 levels were higher than
IgG2a levels in both rCsHSP70/ProR (F(3,3) = 58.91, P =
0.0073) and rCsHSP90/ProR (F(3,3) = 15.21, P = 0.05)
immunized (Fig. 10c). This result indicates that
rCsHSP/ProR complexes polarize the response towards
the Th2 immune response in mice. Antibody isotyping
results showed that rCsHSPs can induce Th2 immune
response as well as Th1 response effectively.
Discussion
HSP acts as a molecular chaperone that enhance host
immune responses [15, 16], and represent dominant
antigens in many infectious diseases. Given their
importance in host-pathogen immune interactions,
these proteins are considered as vaccine candidates
[35]. The present study showed that two recombin-
ant HSPs derived from C. sinensis, rCsHSP70 and
rCsHSP90, can stimulate murine DCs and T cells, as
evidenced by the increase in co-stimulatory molecule
expression and cytokine secretion in the presence of
these proteins. We also found that rCsHSPs can induce
production of antigenic peptide-specific antibodies.
Recombinant HSPs are often contaminated with
bacteria-derived endotoxins, which are responsible for
most in vitro cytokine effects of HSPs [16, 36]. However,
the immunogenicity of HSPs with low endotoxin levels
in DCs has also been reported [18, 19]. Commonly used
Fig. 7 Cytokines secreted from splenocytes of PBS or
rCsHSPs-immunized mice. Mice were immunized on day 0 with PBS or 100 μg rCsHSPs per mouse emulsified in complete Freund’s adjuvant
followed by two booster injections with 100 μg rCsHSPs per mouse emulsified in incomplete Freund’s adjuvant on day 14th and 28th days.
After the 7th day of the last immunization, the splenocytes were isolated from mice and were cultured either in the absence or in the presence of 5 μg/ml
rCsHSP70 (a), rCsHSP90 (b) for 72 h. The results are shown as the mean± standard error (SEM) and are representative of three independent experiments.
**P<0.01, ***P<0.001
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methods for eliminating endotoxin contamination in
experiments using immune cells include endotoxin
measurement using the LAL assay, and co-incubation of
recombinant HSPs with the neutralizing agent poly-
myxin B [37]. In this study, we removed endotoxins
from rCsHSPs with the LAL assay (endotoxin level < 1
EU/ml); as an added precaution, the proteins were
pre-incubated with polymyxin B before they were used
in experiments.
Pathogen-derived HSPs induce an innate immune
response that includes expression of surface markers
on DCs and secretion of inflammatory cytokines [20,
38]. We examined the expression of the co-stimulatory
molecules CD40, CD80, and CD86 as well as MHC I
and MHC II as evidence of DC activation. Both
rCsHSP70 and rCsHSP90 stimulated surface molecule
expression and cytokine secretion (i.e., IL-1β and -6
and TNF-α) in mBMDCs in a dose-dependent manner.
High concentrations of rCsHSPs (≥ 5 μg/ml CsHSP90
and ≥ 25 μg/ml CsHSP70) also induced the secretion of
IL-12 and -10 relative to PBS-treated control groups.
In addition, mBMDCs acquired the capacity for pro-
duction of intracellular IL-12 but not IL-10 in the pres-
ence of rCsHSPs. These results suggest that IL-10 is
secreted early in the immune response. It is assumed
that the capacity of DCs to capture and present
antigens is diminished after initial activation [39]. We
confirmed that both rCsHSP70 and rCsHSP90 stimu-
late cellular uptake and antigen presentation to
mBMDCs. These results extend other reports that
HSPs are potent activators of the innate immune sys-
tem that can induce co-stimulatory molecule expres-
sion and pro-inflammatory cytokine secretion in
mBMDCs [19, 20].
Fig. 8 Surface markers expression in BMDCs treated with CsProR peptide. BMDCs were treated with 1, 5 and 25 μg/ml ProR peptide and then
labeled with FITC-conjugated anti-mouse CD11c or PE-conjugated anti-mouse CD80, CD86, MHCI or MHCII antibodies on ice for 30 min.
Fluorescence intensity was evaluated by flow cytometry
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Fig. 9 Cytokines secretion by BMDCs induced by CsHSP/ProR peptide complexes. rCsHSP70 or rCsHSP90 (1 μg/ml) was mixed with ProR peptide
at a 200:1 peptide:protein molar ratio in binding buffer at 37 °C for 1 h. After polymyxin B treatment for 1 h, BMDCs were treated with rCsHSP70,
rCsHSP90, CsProR peptide or CsHSP/ProR complexes. Levels of secreted cytokines were measured by ELISA. Panel a shows results by CsHSP70/
CsProR and panel b shows results by CsHSP90/CsProR. The results are shown as the mean ± standard error (SEM). *P < 0.05, **P < 0.01, ***P < 0.001
Fig. 10 rCsHSPs stimulate the production of anti-CsProR peptide antibodies via peptide interaction. Freund’s adjuvant (FA) or rCsHSPs (30 μg/ml) was
incubated with CsProR peptide (100 μg/ml) for 1 h at room temperature. C57BL/6 mice were immunized with peptide immersed in FA or rCsHSP/peptide
complexes. a T cells and sera were obtained from immunized mice on day 7 after final immunization. T cells were treated with PBS or 10 μg/ml CsProR
peptide for 72 h, and proliferation was then evaluated by WST-1 assay. Anti-CsProR antibodies (b) and their isotypes (c) detected in immunized mice serum
by ELISA. The results are shown as the mean ± standard error (SEM). *P< 0.05, **P< 0.01, ***P< 0.001 compared to PBS-immunized mice group
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To evaluate T cell activation by rCsHSPs, mBMDCs
activated with rCsHSPs were co-cultured with allogenic
T cells. The number of T cells activated with rCsHSPs
increased over time, and secretion of IL-2 and IFN-γ but
not IL-4 was also increased in T cells obtained from
allogenic as compared to PBS-treated control cells. IFN-γ
was also secreted from splenocytes of rCsHSPs-immunized
mice. These results demonstrate that rCsHSP70 and
rCsHSP90 mainly induce the Th1 immune response
involving CD8+ T cells or macrophages, which could
potentially disable parasites.
HSPs conjugated with peptide have been shown to in-
duce CD8+CTL responses [40, 41]. It has been reported
that bacterial peptides elicit greater immune responses
when bound to HSP [42]. In case of HSP from plants,
HSP/antigen complexes have been shown to increase
production of antibodies against a conjugated reporter
antigen [43]. The Proline-rich (ProR) antigen of C. sinen-
sis has been identified as a potential antigen [44]. In pre-
vious study, we identified that ProR peptide containing
repeated sequences which derived from ProR antigen
has strong antigenicity for clonorchiasis patients’ sera
(data not shown). To ascertain the activity of CsHSP70
and CsHSP90 as an adjuvant for antigenic peptide, we
designed the complex of CsHSPs bound with ProR
peptides. Here we found that ProR peptide alone did
not induce activation of mBMDCs. We speculated
that rCsHSP/ProR peptide complexes would effect-
ively induce an immune response, and generated
CsHSP/ProR peptide complexes using ADP which
increases peptide binding to HSP [18]. Incubation
with CsHSP/ProR peptide complexes stimulated the
secretion of TNF-α, IL-6, and especially IL-1β by
mBMDCs but had no effect on surface marker
expression. We also immunized C57BL/6 mice with
CsHSP/ProR peptide complexes and measured anti-
body production and T cell proliferation. The peptide
alone or mixed with commercial adjuvant did not in-
duce a peptide-specific antibody response in mice,
consistent with another report [45]. However, anti-
ProR peptide antibody production was increased upon
immunization with rCsHSP/ProR. Although rCsHSP90
more strongly stimulated mBMDCs and T cells in vitro,
the in vivo antibody response was greater against
rCsHSP70-bound peptide. On the other hand, T cell pro-
liferation was not induced by CsHSP/peptide complex
immunization. Nonetheless, our findings suggest that
CsHSPs have an adjuvant effect.
Conclusions
In conclusion, we confirmed that rCsHSP70 and rCsHSP90
are antigenic vaccine candidates since they activated the
host immune response through cellular uptake and induc-
tion of antigen presentation. We also showed that CsHSPs
can induce an in vitro immune response to ProR peptide
derived from C. sinensis and have an adjuvant effect that in-
cludes the production of antibodies against ProR peptide.
Our findings suggest that immunization with CsHSP-
peptide conjugates can be an effective strategy for prevent-
ing C. sinensis infection or maturation.
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